Clinical Trial Update: Latanoprost/Brinzolamide BID Versus Latanoprost BID in Patients With OAG or OH [Phase 3]

View source ↗

Summary

A Phase 3 trial comparing latanoprost/brinzolamide to latanoprost alone in open-angle glaucoma or ocular hypertension has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ocular Hypertension
• Open-angle Glaucoma

Drugs mentioned

• Latanoprost (Latanoprost)
• Latanoprost/Brinzolamide (latanoprost/brinzolamide)

Snippet

Sponsor: Adapt Produtos Oftalmológicos Ltda. | Conditions: Open Angle Glaucoma, Ocular Hypertension | Phase 3 | Status: WITHDRAWN